Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GNMX > SEC Filings for GNMX > Form 8-K on 15-Dec-2016All Recent SEC Filings

Show all filings for AEVI GENOMIC MEDICINE, INC.

Form 8-K for AEVI GENOMIC MEDICINE, INC.


15-Dec-2016

Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Othe


Item 5.03. Amendments to Articles of Incorporation or Bylaws? Change in Fiscal Year.

Effective at 12:01 a.m. Eastern Time on December 15, 2016, Medgenics, Inc. (the "Company") changed its name to "Aevi Genomic Medicine, Inc." by filing a Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the "Certificate of Amendment"). The amendment was effected pursuant to Section 242 of the Delaware General Corporation Law, which permits such amendments to be adopted by a corporation's board of directors without stockholder approval. The name change does not affect the rights of the Company's security holders. There were no other changes to the Company's Amended and Restated Certificate of Incorporation in connection with the amendment.

The Company also amended and restated its Second Amended and Restated By-Laws (as so amended and restated, the "Third Amended and Restated By-Laws") solely to reflect the corporate name change. The amendment and restatement of the Second Amended and Restated By-Laws, also effective as of December 15, 2016, does not affect the current rights of the Company's security holders.

Effective December 16, 2016, the Company's common stock, which trades on the Nasdaq Global Market, will cease trading under the ticker symbol "MDGN" and will commence trading under the new ticker symbol "GNMX". Along with the ticker change, the Company's common stock has also been assigned a new CUSIP number of 00835P105. Outstanding certificates for shares of the Company's common stock will continue to be valid and need not be exchanged.

On December 15, 2016, the Company announced the name and ticker symbol change via a press release. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference into this Item 5.03.

The foregoing description of the Certificate of Amendment and the Third Amended and Restated By-Laws does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment and the Third Amended and Restated By-Laws, copies of which are filed as Exhibits 3.1 and 3.2 hereto, respectively, and incorporated by reference herein.



Item 8.01. Other Events.

The information under Item 5.03 regarding the change to the Company's ticker symbol change is incorporated herein by reference into this Item 8.01.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

    Exhibit  Exhibit
    Number

    3.1      Certificate of Amendment to the Amended and Restated Certificate of
             Incorporation of Medgenics, Inc., effective as of December 15, 2016.

    3.2      Third Amended and Restated By-Laws of Aevi Genomic Medicine, Inc.,
             effective as of December 15, 2016.

    99.1     Aevi Genomic Medicine, Inc. Press Release dated December 15, 2016.

  Add GNMX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GNMX - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.